Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancer
about
Therapeutic integration of new molecule-targeted therapies with radiotherapy in lung cancerMiR-200c increases the radiosensitivity of non-small-cell lung cancer cell line A549 by targeting VEGF-VEGFR2 pathwayEffectiveness of combined modality radiotherapy of orthotopic human squamous cell carcinomas in Nu/Nu mice using cetuximab, tirapazamine and MnSOD-plasmid liposome gene therapy.Radiogenomics predicting tumor responses to radiotherapy in lung cancerBMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation.Radiation-induced VEGF-C expression and endothelial cell proliferation in lung cancer.Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to cisplatin and radiation in vivo and in vitro.Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer.Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis.Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non-small cell lung cancer patients treated with definitive radiotherapyDual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesisPreparation, characterization, and evaluation of antitumor effect of Brucea javanica oil cationic nanoemulsions.PolyIC GE11 polyplex inhibits EGFR-overexpressing tumorsRapid Cancer Fluorescence Imaging Using A γ-Glutamyltranspeptidase-Specific Probe For Primary Lung CancerEGFR Inhibition in the Treatment of Non-Small Cell Lung CancerTumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lungRadiosensitising agents for the radiotherapy of cancer: novel molecularly targeted approaches.Effects of irradiation on tumor cell survival, invasion and angiogenesis.The angiogenetic pathway in malignant pleural effusions: Pathogenetic and therapeutic implications.Microenvironment and radiation therapyClosing faucets: the role of anti-angiogenic therapies in malignant pleural diseases.Molecular Targeting of Growth Factor Receptor Signaling in Radiation Oncology.RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt.[EGFR-dependent impact of indol-3-carbinol on radiosensitivity of lung cancer cells].Improvement of orthotopic lung cancer mouse model via thoracotomy and orotracheal intubation enabling in vivo imaging studies.[Effects of rh-endostar in combination with radiotherapy on rats with lung cancer].
P2860
Q27004357-7E5824CE-5234-4A1D-9842-66C2D924FD5DQ28534731-D2C74284-E348-496C-A8A0-6C6CE7C1052DQ33972586-CAFEB666-BBF2-44B0-8A60-D9E9E617A00FQ34049363-70EEDBC0-F6B6-4B32-8251-84D316866138Q34059649-0AD5A871-AC2D-48DB-AFEC-DE2679B09AB1Q34558856-C7765369-7531-4C33-86CE-A9D37286D3A1Q34781075-F54D374D-D809-479A-BCF2-4AC02FEA9906Q35828495-494AF334-782F-4874-BDBC-3CC6F4E76FECQ35836350-A2E7ED49-4B3C-4E66-AA16-8F6E7A23F988Q35914668-47582E3F-DD6C-4572-B2CE-16145D52CA11Q36129640-66DEFCC4-A60A-4E24-B2B5-ABE64C094837Q36981187-A5B770AA-5B9B-42F1-86A1-83345E61F976Q37014230-1267CFF3-62B1-4DCD-A53F-6CD8EA24AF30Q37028949-F5A6F1C4-AA1D-4E6F-9C15-11CC8EC29592Q37240726-D6D9E373-6F80-4B1B-8ECA-9E7872F8A20BQ37308766-B1A88296-695B-45A1-9315-470D8DA33512Q37489947-5E01A933-9315-4854-8226-BF800F6F16F6Q37744732-06415D11-19C1-4329-88A7-28F481513A95Q38058513-9C371471-AABB-453C-98AD-8EA883FB0AF3Q38091084-E28A091E-835F-454B-9FAC-DEB0DDE22229Q38672944-FE508974-265F-4899-A05E-E3E85B19B76FQ38869420-E5D0F344-8919-4B3E-BF13-99D9D9BA4BF1Q38973621-C47076A1-C630-4C55-88B8-3F854720B7BBQ54496147-F2F10ABD-673E-430D-ACD5-4E9FE34A790AQ54564086-23698693-4586-4CEE-B931-94BE39B9AF4AQ55451955-4625BB3E-CEC1-44B5-94F6-C70422FDFE99
P2860
Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancer
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Targeted therapy against VEGFR ...... man non-small-cell lung cancer
@ast
Targeted therapy against VEGFR ...... man non-small-cell lung cancer
@en
type
label
Targeted therapy against VEGFR ...... man non-small-cell lung cancer
@ast
Targeted therapy against VEGFR ...... man non-small-cell lung cancer
@en
prefLabel
Targeted therapy against VEGFR ...... man non-small-cell lung cancer
@ast
Targeted therapy against VEGFR ...... man non-small-cell lung cancer
@en
P2093
P2860
P1476
Targeted therapy against VEGFR ...... man non-small-cell lung cancer
@en
P2093
Anderson Ryan
Juliane M Jürgensmeier
Keiko Shibuya
Luka Milas
Michael S O'Reilly
Satoshi Itasaka
Tomoaki Shintani
P2860
P304
P356
10.1016/J.IJROBP.2007.07.2350
P407
P577
2007-09-24T00:00:00Z